← All medicines

Cancer medicines

Carmustine injection

Independent educational summary · Sources checked November 20, 2026

An intravenous chemotherapy used in selected brain tumors, lymphomas and other cancer regimens. It differs from implanted carmustine wafers.

Profile scope: Carmustine injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Nausea, vomiting, dizziness, fatigue and skin-color changes may occur.

Serious risks and warning signs

Boxed warnings include severe delayed blood-cell suppression and potentially fatal lung injury that may appear years later. Infection, bleeding, liver or kidney problems and tissue injury at the infusion site also require attention.

A question for your healthcare team

How long will blood counts and lung symptoms need monitoring after treatment, and which infusion-site symptoms should I report immediately?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.